R Graphics Output

Total Page:16

File Type:pdf, Size:1020Kb

R Graphics Output Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 ) 141−22−0 ( 0.136 ) Calcium dodecylbenzene sulfonate ( 0.134 ) Deltamethrin ( 0.133 ) o−Phenanthroline ( 0.132 ) Sodium abietate ( 0.131 ) Dicyclohexylamine ( 0.13 ) Kaempferol ( 0.129 ) Benzyl bromoacetate ( 0.128 ) Benzylparaben ( 0.127 ) Bromophenol blue ( 0.126 ) 9004−96−0 ( 0.125 ) Sodium tridecyl sulfate ( 0.125 ) Bisphenol AF ( 0.149 ) Glyceryl monoricinoleate ( 0.147 ) 4−Phenylphenol ( 0.146 ) Temephos ( 0.144 ) Fandosentan potassium salt ( 0.143 ) Linoleic acid ( 0.142 ) Triphenylethylene ( 0.14 ) Haloperidol ( 0.139 ) 2,4−Dihydroxybenzophenone ( 0.139 ) 4−Androstene−3,17−dione ( 0.138 ) YM218 ( 0.137 ) Fulvestrant ( 0.134 ) 4−Nitrophenol ( 0.134 ) SL650472 ( 0.133 ) PharmaGSID_47259 ( 0.132 ) Troglitazone ( 0.13 ) Bis(2−ethylhexyl) phosphate ( 0.13 ) Bisphenol B ( 0.128 ) 6−Hydroxy−2−naphthyl disulfide ( 0.128 ) 2,4,6−Tris(tert−butyl)phenol ( 0.127 ) PharmaGSID_48172 ( 0.125 ) Linolenic acid ( 0.125 ) 2−Chloro−4−phenylphenol ( 0.124 ) 1,5,9−Cyclododecatriene ( 0.121 ) Tamoxifen ( 0.119 ) 2−Ethylhexanoic acid ( 0.118 ) Econazole nitrate ( 0.118 ) Methyl linoleate ( 0.118 ) Octadecanoic acid ( 0.117 ) Mercuric chloride ( 0.116 ) PharmaGSID_48509 ( 0.116 ) Retinol ( 0.115 ) Bromuconazole ( 0.114 ) Fenpyroximate (Z,E) ( 0.113 ) Octadecyl sulfate sodium salt ( 0.112 ) o,p'−DDT ( 0.112 ) Perfluoroheptanoic acid ( 0.112 ) Potassium perfluorooctanesulfonate ( 0.111 ) Hydroxyprogesterone caproate ( 0.11 ) Butylparaben ( 0.11 ) Oleic acid ( 0.109 ) Flufenoxuron ( 0.109 ) Triphenyltin hydroxide ( 0.108 ) Z−Tetrachlorvinphos ( 0.108 ) D5 ( 0.107 ) 2554−06−5 ( 0.123 ) Calcium neodecanoate ( 0.12 ) Phoxim ( 0.119 ) Apomorphine hydrochloride hydrate ( 0.118 ) 4−(2−Methylbutan−2−yl)phenol ( 0.118 ) Estrone ( 0.117 ) Phenyl salicylate ( 0.117 ) FR121052 ( 0.116 ) Octylparaben ( 0.115 ) Corticosterone ( 0.114 ) SAR377142 ( 0.114 ) Clomiphene citrate ( 0.113 ) Isooctadecanoic acid ( 0.112 ) N−Phenyl−1−naphthylamine ( 0.112 ) 612−82−8 ( 0.112 ) C.I. Acid Red 114 ( 0.111 ) AVE3247 ( 0.11 ) Bicalutamide ( 0.109 ) 6683−19−8 ( 0.109 ) Perfluorooctane sulfonic acid ( 0.109 ) Eosin ( 0.108 ) 2,4,6−Tribromophenol ( 0.108 ) Pioglitazone hydrochloride ( 0.107 ) Carbamazepine ( 0.107 ) 13680−35−8 ( 0.106 ) Propylparaben ( 0.106 ) Dieldrin ( 0.105 ) Clotrimazole ( 0.105 ) 2440−22−4 ( 0.104 ) 27344−41−8 ( 0.104 ) Tamoxifen citrate ( 0.104 ) Myristic acid ( 0.104 ) Hexadecanoic acid ( 0.103 ) Kepone ( 0.103 ) 13171−00−1 ( 0.102 ) 2,6−Di−tert−butyl−4−methoxyphenol ( 0.102 ) Metconazole ( 0.101 ) (−)−alpha−Pinene ( 0.101 ) UK−416244 ( 0.101 ) p,p'−DDE ( 0.101 ) 3,3',5,5'−Tetrabromobisphenol A ( 0.1 ) Dicyclohexyl phthalate ( 0.1 ) Butylated hydroxytoluene ( 0.1 ) Dodecylphenol ( 0.1 ) Codlelure ( 0.099 ) 95−38−5 ( 0.107 ) Indomethacin ( 0.107 ) Genistein ( 0.106 ) Bisphenol A ( 0.105 ) Pyridaben ( 0.105 ) Dodecyl sulfate triethanolamine ( 0.104 ) 21145−77−7 ( 0.104 ) Perfluorononanoic acid ( 0.104 ) Amitraz ( 0.104 ) Thiocarbazide ( 0.103 ) Phenolphthalein ( 0.103 ) Silwet L77 ( 0.103 ) 4,4'−Sulfonyldiphenol ( 0.102 ) 1−Cedr−8−en−9−ylethanone ( 0.102 ) Acid yellow 11 ( 0.101 ) p,p'−DDT ( 0.101 ) Phenylparaben ( 0.101 ) 4−Cumylphenol ( 0.1 ) 7−(Dimethylamino)−4−methylcoumarin ( 0.1 ) Octamethylcyclotetrasiloxane ( 0.1 ) 26040−51−7 ( 0.1 ) 2−Mercaptobenzothiazole ( 0.099 ) Pyraclostrobin ( 0.099 ) 4−(Butan−2−yl)phenol ( 0.098 ) Methyl salicylate ( 0.098 ) Farnesol ( 0.098 ) Acid Red 337 ( 0.098 ) 2,6−Di−tert−butyl−4−ethylphenol ( 0.097 ) Tributyltin benzoate ( 0.097 ) 2−Chloro−N−phenylacetamide ( 0.096 ) 2−Ethylhexylparaben ( 0.096 ) 4,4',4−Ethane−1,1,1−triyltriphenol ( 0.096 ) Monotridecyl phosphate ( 0.095 ) FR150011 ( 0.094 ) N−Methyldioctylamine ( 0.094 ) Auramine hydrochloride ( 0.094 ) 1,4−Dihydroxy−2−naphthoic acid ( 0.094 ) Dicofol ( 0.093 ) Tris(2−ethylhexyl) trimellitate ( 0.093 ) Igepal CO−890 ( 0.093 ) Triphenylborane ( 0.092 ) 4−(Hexyloxy)phenol ( 0.092 ) 94−81−5 ( 0.092 ) Bromocriptine mesylate ( 0.092 ) ddI; Didanosine ( 0.091 ) Dibutyltin dichloride ( 0.099 ) Pentylcinnamaldehyde ( 0.098 ) Decanoic acid ( 0.098 ) Basic Blue 7 ( 0.098 ) Decanal ( 0.098 ) Endosulfan I ( 0.097 ) Hydroxyflutamide ( 0.096 ) 1−Decanamine ( 0.096 ) Iopanoic acid ( 0.096 ) Methyl red ( 0.095 ) 4−Butylphenol ( 0.095 ) Heptachlor ( 0.094 ) 1,3,5−Triisopropylbenzene ( 0.094 ) HMR1426 ( 0.094 ) Tetrabutyltin ( 0.094 ) 1,3−Diphenyl−1,3−propanedione ( 0.093 ) Endrin ( 0.093 ) Azobenzene ( 0.093 ) Epoxyheptachlor ( 0.092 ) 4,4'−Dichlorodiphenyl sulfone ( 0.092 ) Glyceryl monooleate ( 0.092 ) Kresoxim−methyl ( 0.091 ) SAR150640 ( 0.091 ) Hexaflumuron ( 0.091 ) 4−Nonylphenol, branched ( 0.091 ) 263553−33−9 ( 0.09 ) Elzasonan ( 0.09 ) 3,3'−Dimethoxybenzidine ( 0.09 ) (Dodecylamine ( 0.09 ) Acid orange 156 ( 0.09 ) Didecyldimethylammonium chloride ( 0.09 ) Perfluorooctanesulfonamide ( 0.089 ) 3,3'−Dimethylbenzidine ( 0.089 ) Tricresyl phosphate ( 0.089 ) 81741−28−8 ( 0.089 ) Nonanoic acid ( 0.089 ) Diphenylmercury(II) ( 0.089 ) 5HPP−33 ( 0.088 ) Diallyl phthalate ( 0.088 ) 1323−19−9 ( 0.088 ) 9004−82−4 ( 0.088 ) PharmaGSID_48511 ( 0.087 ) CI−1044 ( 0.087 ) 1,2−Dibromo−2,4−dicyanobutane ( 0.087 ) 41481−66−7 ( 0.087 ) Acifluorfen ( 0.091 ) Ammonium perfluorooctanoate ( 0.091 ) Daidzein ( 0.09 ) Retinol acetate ( 0.09 ) Methoxychlor ( 0.09 ) (Z)−11−Hexadecenal ( 0.09 ) Potassium perfluorohexanesulfonate ( 0.09 ) Tributyltin methacrylate ( 0.09 ) Tributyltin chloride ( 0.089 ) Mirex ( 0.089 ) 4−tert−Butylphenol ( 0.089 ) Sodium dodecylbenzenesulfonate ( 0.089 ) Cyclopamine ( 0.089 ) Dibutyl nonanedioate ( 0.089 ) Di−tert−butyl peroxide ( 0.089 ) Vinclozolin ( 0.088 ) Sodium dodecyl sulfate ( 0.088 ) 2−Ethylhexyl octadecanoate ( 0.088 ) Aspirin ( 0.088 ) Dodecylbenzenesulfonic acid ( 0.087 ) Chlorophacinone ( 0.087 ) Cremophor(R) EL ( 0.087 ) Allura Red C.I.16035 ( 0.087 ) Tannic acid ( 0.087 ) SR271425 ( 0.087 ) Fenvalerate ( 0.086 ) Dodecyl gallate ( 0.086 ) (2−Dodecenyl)succinic anhydride ( 0.086 ) SR58611 ( 0.086 ) Gemfibrozil ( 0.086 ) CP−532623 ( 0.086 ) Atorvastatin calcium ( 0.085 ) Sulprofos ( 0.085 ) 2627−95−4 ( 0.085 ) Oxazepam ( 0.085 ) Amiodarone hydrochloride ( 0.085 ) Bisphenol F ( 0.085 ) 2−Ethylhexyl diphenyl phosphate ( 0.085 ) Difenoconazole ( 0.085 ) Haloxyfop−methyl ( 0.084 ) 4−(1,1,3,3−Tetramethylbutyl)phenol ( 0.084 ) Rotenone ( 0.084 ) Diisodecylphenyl phosphite ( 0.084 ) 647−42−7 ( 0.084 ) 139−88−8 ( 0.083 ) 127−51−5 ( 0.087 ) 2694−54−4 ( 0.087 ) Perfluorodecanoic acid ( 0.086 ) 1−(Bromomethyl)−3−phenoxybenzene ( 0.086 ) Zenarestat ( 0.086 ) SB243213A ( 0.086 ) Docusate sodium ( 0.086 ) CP−612372 ( 0.086 ) Diisodecyl hexanedioate ( 0.086 ) Triisodecyl trimellitate ( 0.085 ) 1,4−Diaminoanthraquinone ( 0.085 ) Triphenylphosphine ( 0.085 ) 4,4'−Di−tert−butylbiphenyl ( 0.085 ) 2,4,6−Trichlorophenol ( 0.085 ) Triisononyl trimellitate ( 0.085 ) Thifensulfuron−methyl ( 0.085 ) Fenpropimorph ( 0.084 ) Tris(2,3−dibromopropyl) phosphate ( 0.084 ) 78−63−7 ( 0.084 ) Sodium 4−octylbenzenesulfonate ( 0.084 ) Sodium hexyldecyl sulfate ( 0.084 ) 8:2 FTOH (fluorotelomer alcohol) ( 0.083 ) Chrysophenine ( 0.083 ) FR130739 ( 0.083 ) 2−Hydroxy−4−methoxybenzophenone ( 0.083 ) Methylbenzethonium chloride ( 0.083 ) Pyraflufen−ethyl ( 0.083 ) Tebufenpyrad ( 0.083 ) Hexadecyltrimethylammonium bromide ( 0.082 ) SSR149415 ( 0.082 ) Rhodamine B ( 0.082 ) Ergocalciferol ( 0.082 ) Flavone ( 0.082 ) Perfluoroundecanoic acid ( 0.082 ) Iprodione ( 0.082 ) 118−56−9 ( 0.081 ) Lindane ( 0.081 ) 27323−41−7 ( 0.081 ) Besonprodil ( 0.081 ) Maleic acid ( 0.081 ) (4Z)−4−Decenal ( 0.08 ) SSR126768 ( 0.08 ) FD&C Green No. 3 ( 0.08 ) UK−076654 ( 0.08 ) Epoxiconazole ( 0.08 ) Prochloraz ( 0.083 ) 1,1−Bis(3,4−dimethylphenyl)ethane ( 0.083 ) Hydramethylnon ( 0.083 ) Ethyl benzoate ( 0.083 ) C.I. Direct Red 81 disodium salt ( 0.083 ) Coumarin ( 0.083 ) Heptanal ( 0.082 ) 2−Hexyl−1−decanol ( 0.082 ) CP−283097 ( 0.082 ) Chlorfenapyr ( 0.082 ) Sodium tetradecyl sulfate ( 0.082 ) Sodium 2−phenylphenate tetrahydrate ( 0.082 ) 4−Chloro−3−methylphenol ( 0.081 ) AVE8488
Recommended publications
  • 36Th ITC Report
    Thursday August 17, 1995 Part V Environmental Protection Agency Thirty-Sixth Report of the TSCA Interagency Testing Committee to the Administrator; Receipt of Report, Request for Comments, Solicitation of Use and Exposure Data; Notice federal register 42981 42982 Federal Register / Vol. 60, No. 159 / Thursday, August 17, 1995 / Notices ENVIRONMENTAL PROTECTION comments and data in electronic form ``OPPTS±41043'' (including comments AGENCY must be identified by the docket number and data submitted electronically as OPPT±41043. No CBI should be described below). A public version of [OPPTS±41043; FRL±4965±6] submitted through e-mail. Electronic this record, including printed, paper Thirty-Sixth Report of the TSCA comments on this notice may be filed versions of electronic comments, which Interagency Testing Committee to the online at many Federal Depository does not include any information Administrator; Receipt of Report, Libraries. Additional information on claimed as confidential business Request for Comments, Solicitation of electronic submissions can be found in information (CBI), is available for Use and Exposure Data Unit III of this document. inspection from 12 noon to 4 p.m., FOR FURTHER INFORMATION CONTACT: Monday through Friday, excluding legal AGENCY: Environmental Protection Susan B. Hazen, Director, holidays. The public record is located in Agency (EPA). Environmental Assistance Division the TSCA Nonconfidential Information ACTION: Notice. (7408), Office of Pollution Prevention Center, Rm. NE-B607, 401 M St., SW., and Toxics, Environmental Protection Washington, DC 20460. SUMMARY: The TSCA Interagency Agency, 401 M Street, SW., Rm. E± Electronic comments can be sent Testing Committee (ITC), established 543B, Washington, DC 20460, (202) directly to EPA at: under section 4(e) of the Toxic 554±1404, TDD (202) 554±0551, [email protected] Substances Control Act (TSCA), Internet: TSCA- transmitted its Thirty-Sixth Report to [email protected].
    [Show full text]
  • Oxidative Stress and BPA Toxicity: an Antioxidant Approach for Male and Female Reproductive Dysfunction
    antioxidants Review Oxidative Stress and BPA Toxicity: An Antioxidant Approach for Male and Female Reproductive Dysfunction Rosaria Meli 1, Anna Monnolo 2, Chiara Annunziata 1, Claudio Pirozzi 1,* and Maria Carmela Ferrante 2,* 1 Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131 Naples, Italy; [email protected] (R.M.); [email protected] (C.A.) 2 Department of Veterinary Medicine and Animal Productions, Federico II University of Naples, Via Delpino 1, 80137 Naples, Italy; [email protected] * Correspondence: [email protected] (C.P.); [email protected] (M.C.F.) Received: 15 April 2020; Accepted: 7 May 2020; Published: 10 May 2020 Abstract: Bisphenol A (BPA) is a non-persistent anthropic and environmentally ubiquitous compound widely employed and detected in many consumer products and food items; thus, human exposure is prolonged. Over the last ten years, many studies have examined the underlying molecular mechanisms of BPA toxicity and revealed links among BPA-induced oxidative stress, male and female reproductive defects, and human disease. Because of its hormone-like feature, BPA shows tissue effects on specific hormone receptors in target cells, triggering noxious cellular responses associated with oxidative stress and inflammation. As a metabolic and endocrine disruptor, BPA impairs redox homeostasis via the increase of oxidative mediators and the reduction of antioxidant enzymes, causing mitochondrial dysfunction, alteration in cell signaling pathways, and induction of apoptosis. This review aims to examine the scenery of the current BPA literature on understanding how the induction of oxidative stress can be considered the “fil rouge” of BPA’s toxic mechanisms of action with pleiotropic outcomes on reproduction.
    [Show full text]
  • Chapter 21 the Chemistry of Carboxylic Acid Derivatives
    Instructor Supplemental Solutions to Problems © 2010 Roberts and Company Publishers Chapter 21 The Chemistry of Carboxylic Acid Derivatives Solutions to In-Text Problems 21.1 (b) (d) (e) (h) 21.2 (a) butanenitrile (common: butyronitrile) (c) isopentyl 3-methylbutanoate (common: isoamyl isovalerate) The isoamyl group is the same as an isopentyl or 3-methylbutyl group: (d) N,N-dimethylbenzamide 21.3 The E and Z conformations of N-acetylproline: 21.5 As shown by the data above the problem, a carboxylic acid has a higher boiling point than an ester because it can both donate and accept hydrogen bonds within its liquid state; hydrogen bonding does not occur in the ester. Consequently, pentanoic acid (valeric acid) has a higher boiling point than methyl butanoate. Here are the actual data: INSTRUCTOR SUPPLEMENTAL SOLUTIONS TO PROBLEMS • CHAPTER 21 2 21.7 (a) The carbonyl absorption of the ester occurs at higher frequency, and only the carboxylic acid has the characteristic strong, broad O—H stretching absorption in 2400–3600 cm–1 region. (d) In N-methylpropanamide, the N-methyl group is a doublet at about d 3. N-Ethylacetamide has no doublet resonances. In N-methylpropanamide, the a-protons are a quartet near d 2.5. In N-ethylacetamide, the a- protons are a singlet at d 2. The NMR spectrum of N-methylpropanamide has no singlets. 21.9 (a) The first ester is more basic because its conjugate acid is stabilized not only by resonance interaction with the ester oxygen, but also by resonance interaction with the double bond; that is, the conjugate acid of the first ester has one more important resonance structure than the conjugate acid of the second.
    [Show full text]
  • Dipropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary December 2017
    DiPropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary December 2017 DiPropylene Glycol Ethyl Ether (DPGEE) [Ethyl DIPROXITOL] Product Stewardship Summary (CAS number 30025-38-8) Chemical Formula for DPGEE C8H18 O3 What is DPGEE? DPGEE is a glycol ether based on Propylene oxide and ethanol. It is a speciality solvent having a bi- functional nature (ether-alcohol). It is a clear liquid with an ethereal odour. The Shell Chemicals range of Propylene oxide-based glycol ethers are sold under the trade name PROXITOL. How is DPGEE Used? It is used as an intermediate and in formulations in industrial, professional or consumer applications, mainly in surface coatings and printing inks and paints, cleaners, agrochemical or de-icing/anti-icing formulations. Health, Safety and Environmental Considerations DPGEE is flammable liquids with a flashpoint of 180 0F/82 0C. DPGEE is an isomer mix, of which the main component is 1-Ethoxypropanol-2 (typically 98% or more). Shell PROXITOLs are not classified as carcinogens or mutagens, are not expected to cause cancer in humans, nor do they impair fertility or damage the developing foetus. DPGEE is of low toxicity towards aquatic organisms. They are completely miscible with water, biodegradable and not expected to bio-accumulate. Storing and Transporting DPGEE DPGEE is transported by tank truck, rail car and vessel, primarily in bulk quantities, but also as packed product. Due to its flammability, they are classified as hazardous for transport under transport regulations. Glycol Ethers should be stored at ambient temperatures away from sources of ignition and substances with oxidising or corrosive properties.
    [Show full text]
  • Common and Chemical Names of Herbicides Approved by the WSSA
    Weed Science 2010 58:511–518 Common and Chemical Names of Herbicides Approved by the Weed Science Society of America Below is the complete list of all common and chemical of herbicides as approved by the International Organization names of herbicides approved by the Weed Science Society of for Standardization (ISO). A sponsor may submit a proposal America (WSSA) and updated as of September 1, 2010. for a common name directly to the WSSA Terminology Beginning in 1996, it has been published yearly in the last Committee. issue of Weed Science with Directions for Contributors to A herbicide common name is not synonymous with Weed Science. This list is published in lieu of the selections a commercial formulation of the same herbicide, and in printed previously on the back cover of Weed Science. Only many instances, is not synonymous with the active ingredient common and chemical names included in this complete of a commercial formulation as identified on the product list should be used in WSSA publications. In the absence of label. If the herbicide is a salt or simple ester of a parent a WSSA-approved common name, the industry code number compound, the WSSA common name applies to the parent as compiled by the Chemical Abstracts Service (CAS) with compound only. CAS systematic chemical name or the systematic chemical The chemical name used in this list is that preferred by the name alone may be used. The current approved list is also Chemical Abstracts Service (CAS) according to their system of available at our web site (www.wssa.net).
    [Show full text]
  • Transport of Dangerous Goods
    ST/SG/AC.10/1/Rev.16 (Vol.I) Recommendations on the TRANSPORT OF DANGEROUS GOODS Model Regulations Volume I Sixteenth revised edition UNITED NATIONS New York and Geneva, 2009 NOTE The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. ST/SG/AC.10/1/Rev.16 (Vol.I) Copyright © United Nations, 2009 All rights reserved. No part of this publication may, for sales purposes, be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying or otherwise, without prior permission in writing from the United Nations. UNITED NATIONS Sales No. E.09.VIII.2 ISBN 978-92-1-139136-7 (complete set of two volumes) ISSN 1014-5753 Volumes I and II not to be sold separately FOREWORD The Recommendations on the Transport of Dangerous Goods are addressed to governments and to the international organizations concerned with safety in the transport of dangerous goods. The first version, prepared by the United Nations Economic and Social Council's Committee of Experts on the Transport of Dangerous Goods, was published in 1956 (ST/ECA/43-E/CN.2/170). In response to developments in technology and the changing needs of users, they have been regularly amended and updated at succeeding sessions of the Committee of Experts pursuant to Resolution 645 G (XXIII) of 26 April 1957 of the Economic and Social Council and subsequent resolutions.
    [Show full text]
  • Effect of Cooking Loss in the Assessment of Vitamin Intake for Epidemiological Data in Japan
    European Journal of Clinical Nutrition (2011) 65, 546–552 & 2011 Macmillan Publishers Limited All rights reserved 0954-3007/11 www.nature.com/ejcn ORIGINAL ARTICLE Effect of cooking loss in the assessment of vitamin intake for epidemiological data in Japan M Kobayashi1,2, HY Adachi2, J Ishihara2,3 and S Tsugane2 for the JPHC FFQ Validation Study Group 1Department of Food Science, Faculty of Home Economics, Otsuma Women’s University, Tokyo, Japan; 2Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan and 3Department of Nutrition, Junior College of Tokyo University of Agriculture, Tokyo, Japan Background/Objectives: The effect of cooking loss on vitamin intake is an important consideration in dietary and epidemiological studies in Japanese. However, because few published food values have considered cooking effect, allowing for cooking loss in the assessment of vitamin intake in Japan has been difficult. Subjects/Methods: Seven-day dietary records and a fasting blood sample were collected from 102 men and 113 women in August of 1994 or 1995. Vitamin intake were estimated using two food databases, one composed of raw food only and the second of cooked food. Estimates were compared with blood levels. Results: Water-soluble vitamin intake using a food database including cooked food was lower than intakes estimated using a database composed of raw food only, except for pantothenic acid and vitamin B12 intake. In particular, vitamin B1 intake was 18.9% lower in men and 16.8% lower in women. However, when subjects were classified into the same and adjacent categories by joint classification by quintiles, appreciable change in ranking of a subject was not observed.
    [Show full text]
  • Herbicide Mode of Action Table High Resistance Risk
    Herbicide Mode of Action Table High resistance risk Chemical family Active constituent (first registered trade name) GROUP 1 Inhibition of acetyl co-enzyme A carboxylase (ACC’ase inhibitors) clodinafop (Topik®), cyhalofop (Agixa®*, Barnstorm®), diclofop (Cheetah® Gold* Decision®*, Hoegrass®), Aryloxyphenoxy- fenoxaprop (Cheetah®, Gold*, Wildcat®), fluazifop propionates (FOPs) (Fusilade®), haloxyfop (Verdict®), propaquizafop (Shogun®), quizalofop (Targa®) Cyclohexanediones (DIMs) butroxydim (Factor®*), clethodim (Select®), profoxydim (Aura®), sethoxydim (Cheetah® Gold*, Decision®*), tralkoxydim (Achieve®) Phenylpyrazoles (DENs) pinoxaden (Axial®) GROUP 2 Inhibition of acetolactate synthase (ALS inhibitors), acetohydroxyacid synthase (AHAS) Imidazolinones (IMIs) imazamox (Intervix®*, Raptor®), imazapic (Bobcat I-Maxx®*, Flame®, Midas®*, OnDuty®*), imazapyr (Arsenal Xpress®*, Intervix®*, Lightning®*, Midas®* OnDuty®*), imazethapyr (Lightning®*, Spinnaker®) Pyrimidinyl–thio- bispyribac (Nominee®), pyrithiobac (Staple®) benzoates Sulfonylureas (SUs) azimsulfuron (Gulliver®), bensulfuron (Londax®), chlorsulfuron (Glean®), ethoxysulfuron (Hero®), foramsulfuron (Tribute®), halosulfuron (Sempra®), iodosulfuron (Hussar®), mesosulfuron (Atlantis®), metsulfuron (Ally®, Harmony®* M, Stinger®*, Trounce®*, Ultimate Brushweed®* Herbicide), prosulfuron (Casper®*), rimsulfuron (Titus®), sulfometuron (Oust®, Eucmix Pre Plant®*, Trimac Plus®*), sulfosulfuron (Monza®), thifensulfuron (Harmony®* M), triasulfuron (Logran®, Logran® B-Power®*), tribenuron (Express®),
    [Show full text]
  • Folic Acid, Pyridoxine, and Cyanocobalamin Combination
    ORIGINAL INVESTIGATION Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women The Women’s Antioxidant and Folic Acid Cardiovascular Study William G. Christen, ScD; Robert J. Glynn, ScD; Emily Y. Chew, MD; Christine M. Albert, MD; JoAnn E. Manson, MD Background: Observational epidemiologic studies indi- and visually significant AMD, defined as confirmed in- cate a direct association between homocysteine concentra- cident AMD with visual acuity of 20/30 or worse attrib- tion in the blood and the risk of age-related macular degen- utable to this condition. eration (AMD), but randomized trial data to examine the effect of therapy to lower homocysteine levels in AMD are Results:Afteranaverageof7.3yearsoftreatmentandfollow- lacking. Our objective was to examine the incidence of AMD up, there were 55 cases of AMD in the combination treat- in a trial of combined folic acid, pyridoxine hydrochloride ment group and 82 in the placebo group (relative risk, 0.66; (vitamin B6), and cyanocobalamin (vitamin B12) therapy. 95% confidence interval, 0.47-0.93 [P=.02]). For visually significant AMD, there were 26 cases in the combination Methods: We conducted a randomized, double-blind, treatment group and 44 in the placebo group (relative risk, placebo-controlled trial including 5442 female health care 0.59; 95% confidence interval, 0.36-0.95 [P=.03]). professionals 40 years or older with preexisting cardio- vascular disease or 3 or more cardiovascular disease risk Conclusions: These randomized trial data from a large factors. A total of 5205 of these women did not have a cohort of women at high risk of cardiovascular disease diagnosis of AMD at baseline and were included in this indicate that daily supplementation with folic acid, pyri- analysis.
    [Show full text]
  • WO 2013/037955 Al 21 March 2013 (21.03.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2013/037955 Al 21 March 2013 (21.03.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A01N 25/00 (2006.01) A OIN 43/653 (2006.01) kind of national protection available): AE, AG, AL, AM, A0 41/06 (2006.01) A01N 37/50 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP2012/068096 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 14 September 2012 (14.09.2012) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 1118 1702.9 16 September 201 1 (16.09.201 1) EP (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): BAYER GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, INTELLECTUAL PROPERTY GMBH [DE/DE]; Al- UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, fred-Nobel-Str.
    [Show full text]
  • Chlorinated and Polycyclic Aromatic Hydrocarbons in Riverine and Estuarine Sediments from Pearl River Delta, China
    Environmental Pollution 117 (2002) 457–474 www.elsevier.com/locate/envpol Chlorinated and polycyclic aromatic hydrocarbons in riverine and estuarine sediments from Pearl River Delta, China Bi-Xian Maia,*, Jia-Mo Fua, Guo-Ying Shenga, Yue-Hui Kanga, Zheng Lina, Gan Zhanga, Yu-Shuan Mina, Eddy Y. Zengb aState Key Lab Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, PO Box 1130, Guangzhou, Guangdong 510640, People’s Republic of China bSouthern California Coastal Water Research Project, 7171 Fenwick Lane, Westminster, CA 92683, USA Received 5 January 2001; accepted 3 July 2001 ‘‘Capsule’’: Sediments of the Zhujiang River and Macao Harbor have the potential to be detrimental to biological systems. Abstract Spatial distribution of chlorinated hydrocarbons [chlorinated pesticides (CPs) and polychlorinated biphenyls (PCBs)] and poly- cyclic aromatic hydrocarbons (PAHs) was measured in riverine and estuarine sediment samples from Pearl River Delta, China, collected in 1997. Concentrations of CPs of the riverine sediment samples range from 12 to 158 ng/g, dry weight, while those of PCBs range from 11 to 486 ng/g. The CPs concentrations of the estuarine sediment samples are in the range 6–1658 ng/g, while concentrations of PCBs are in the range 10–339 ng/g. Total PAH concentration ranges from 1168 to 21,329 ng/g in the riverine sediment samples, whereas the PAH concentration ranges from 323 to 14,812ng/g in the sediment samples of the Estuary. Sediment samples of the Zhujiang River and Macao harbor around the Estuary show the highest concentrations of CPs, PCBs, and PAHs. Possible factors affecting the distribution patterns are also discussed based on the usage history of the chemicals, hydrologic con- dition, and land erosion due to urbanization processes.
    [Show full text]
  • Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium Fortunei
    International Journal of Molecular Sciences Article Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium fortunei Chun-Hao Chang 1, Semon Wu 2, Kai-Cheng Hsu 3,4, Wei-Jan Huang 5,6 and Jih-Jung Chen 7,8,9,* 1 Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan; [email protected] 2 Department of Life Science, Chinese Culture University, Taipei 110, Taiwan; [email protected] 3 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan; [email protected] 4 Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan 5 Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; [email protected] 6 Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan 7 Department of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan 8 Faculty of Pharmacy, National Yang-Ming University, Taipei 112, Taiwan 9 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2826-7195; Fax: +886-2-2823-2940 Abstract: Five new compounds, eupatodibenzofuran A (1), eupatodibenzofuran B (2), 6-acetyl-8- methoxy-2,2-dimethylchroman-4-one (3), eupatofortunone (4), and eupatodithiecine (5), have been isolated from the aerial part of Eupatorium fortunei, together with 11 known compounds (6-16).
    [Show full text]